Epistaxis Global Clinical Trials Review, H1, 2012

GlobalData, March 2012, Pages: 60

Epistaxis Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Epistaxis Global Clinical Trials Review, H1, 2012" provides data on the Epistaxis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Epistaxis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Epistaxis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Epistaxis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Epistaxis , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Epistaxis
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Epistaxis
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Epistaxis Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Troikaa Pharmaceuticals Ltd.
Clinical Trial Overview of Troikaa Pharmaceuticals Ltd.
HemCon Medical Technologies, Inc.
Clinical Trial Overview of HemCon Medical Technologies, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
University of California, San Diego
Clinical Trial Overview of University of California, San Diego
University of Minnesota
Clinical Trial Overview of University of Minnesota
Georgia Health Sciences University
Clinical Trial Overview of Georgia Health Sciences University
The University of Kansas
Clinical Trial Overview of The University of Kansas
Ottawa Hospital Research Institute
Clinical Trial Overview of Ottawa Hospital Research Institute
Hospital Universitario Ramon y Cajal
Clinical Trial Overview of Hospital Universitario Ramon y Cajal
IRCCS Policlinico San Matteo
Clinical Trial Overview of IRCCS Policlinico San Matteo
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
University of Calgary
Clinical Trial Overview of University of Calgary
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Epistaxis Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Epistaxis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Epistaxis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Epistaxis Therapeutics Clinical Trials, Europe, Top Countries, 2012-
Epistaxis Therapeutics Clinical Trials, North America, Top Countries, 2012-
Epistaxis Therapeutics Clinical Trials, G7 Countries, 2012-
Epistaxis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Epistaxis Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Epistaxis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Epistaxis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Epistaxis Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Epistaxis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Epistaxis Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Epistaxis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Epistaxis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Troikaa Pharmaceuticals Ltd., 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by HemCon Medical Technologies, Inc., 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgia Health Sciences University, 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Kansas, 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Ramon y Cajal, 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico San Matteo, 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012-
Epistaxis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2012-

List of Figures
Epistaxis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Epistaxis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Epistaxis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Epistaxis Therapeutics Clinical Trials, Europe, Top Countries (%), 2012-
Epistaxis Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Epistaxis Therapeutics Clinical Trials, G7 Countries (%), 2012-
Epistaxis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Epistaxis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Epistaxis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Epistaxis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Epistaxis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Epistaxis Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Epistaxis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Epistaxis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US
• Clinical Trial Management Systems (CTMS) - Global Strategic Business Report
• 2012 Good Clinical Practice: A Question & Answer Reference Guide
• PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013
• Healthcare Contract Research Outsourcing Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
• Cellular Therapy and Cord Blood 2013 Market Report
• Global Molecular Diagnostics Market & Future Forecast to 2017 Overview
• Global Healthcare Cold Chain Logistics Market Report & Forecast (2012-2017)
• Medical Nutrition - A Global Market Overview
• Russia Clinical Trial Market Opportunity Analysis